HK Stock Market Move | Brain-computer interface concept stocks mostly rose, the industry benefits from the key layout of the "13th Five-Year Plan", and intensive catalyzation at home and abroad.

date
09:46 08/01/2026
avatar
GMT Eight
The concept stocks of brain-computer interface are mostly up. As of the time of reporting, BrainCo Ltd. (06681) rose by 7.91% to 7.78 Hong Kong dollars; MicroPort NeuroTech (02172) rose by 6.2% to 13.19 Hong Kong dollars; BrainTech (02203) rose by 3.56% to 0.233 Hong Kong dollars.
Concept stocks related to brain-computer interfaces are mostly on the rise. As of the deadline, Brainco Aurora-B (06681) rose by 7.91%, closing at 7.78 Hong Kong dollars; MICROPORT NEURO (02172) rose by 6.2%, closing at 13.19 Hong Kong dollars; BRAINHOLE TECH (02203) rose by 3.56%, closing at 0.233 Hong Kong dollars. On the news front, on January 7th, the Ministry of Industry and Information Technology and eight other departments issued the "Implementation Opinions on Special Action for 'Artificial Intelligence + Manufacturing'", which proposed accelerating the upgrading of intelligent terminals. Focusing on key scenarios such as industrial inspection and remote medical care, the industrialization and commercialization process of new terminals such as augmented reality/virtual reality (AR/VR) wearable devices and brain-computer interfaces are to be sped up. Guosen Securities believes that the brain-computer interface industry, as a high-growth track integrating multidisciplinary cutting-edge technologies, is entering a key stage of large-scale application driven by strong policy support, the landing of medical insurance payments, and continuous technological breakthroughs. Guosen pointed out that brain-computer interfaces have reached a critical point of "technological breakthrough transitioning to commercialization", anchoring the three main lines of "policy + technology + scenario". The current industry benefits from the focus layout of the "14th Five-Year Plan", policy dividends such as medical insurance coding and the implementation of medical device standards, coupled with the mass production expectations of Neuralik and domestic clinical breakthroughs, the global market size is expected to experience explosive growth. With the continuous development of technologies such as chips, electrodes, algorithms, and the improvement of regulations and standards, brain-computer interface products are expected to undergo intensive commercialization in the coming years.